FIELD: chemistry.
SUBSTANCE: invention concerns new compounds of the formula (I) and their pharmaceutically acceptable salts. Claimed compounds have antibacterial effect. In formula (I) 
, X is 
; R1 is i) hydrogen, ii) (CH2)nNR5R6, iv) NRCO2R, v) (C1-6alkyl)CN, CN, (CH2)pOH; Y is NR*, O or S(O)p; 
is phenyl or 5-6-member heteroaryl with N or S as heteroatoms; R3 is NR(C=X2)R12, NR*R12, or -(O)n-5-6-member heteroaryl with 1-3 heteroatoms selected out of N, O, which can be linked over either carbon atom or heteroatom; the indicated 5-6-member heteroaryl can be optionally substituted by 1-3 groups of R7; R4, R4a, R4b and R4c are independently i) hydrogen, ii) halogen; other radicals are defined in the claim.
EFFECT: pharmaceutical composition containing effective volume of the claimed compound.
13 cl, 1 dwg, 194 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OXAZOLIDINONE DERIVATIVES | 2001 |
|
RU2292345C9 |
| AZABICYCLO-QUINOLONE CAROBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS AND INTERMEDIATE PRODUCTS FOR THEIR SYNTHESIS | 1989 |
|
RU2049777C1 |
| NEW DERIVATIVES OF PYRIDONE CARBOXYLIC ACIDS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING PATIENTS WITH INFECTIOUS DISEASES | 1993 |
|
RU2161154C2 |
| METHOD OF PREPARING TROVAFLOXACIN | 1999 |
|
RU2167867C2 |
| NEW COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS | 2019 |
|
RU2798336C2 |
| AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
| PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND | 2017 |
|
RU2739983C2 |
| TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677698C1 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| TRIAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677697C1 |
